Legal and biological safety of legal reprocessing of medicalhospital materials

Autores

  • Paula Z. P. F. Pinto Master in Health, Laboratorial Medicine and Forensic Technology. Institute of Biology Roberto Alcântara Gomes, University of the State of Rio de Janeiro. Rio de Janeiro, RJ, Brazil. https://orcid.org/0000-0002-2463-3932
  • Nelson Massini Legal Medicine Department. University of the State of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.

DOI:

https://doi.org/10.12957/bjhbs.2020.59717

Palavras-chave:

Single use of catheters, Ablation catheter, Hospital infection, Catheter cleaning and sterilization, Quality control.

Resumo

Introduction: Procedures using disposable materials in the
health area began to be performed, for example in cardiac
catheterization, which has a high prevalence of morbidity and
mortality. Objective: To justify and reaffirm the reuse of single-
use catheters in surgeries, as it is justified by the economic
benefit gained from replacing the purchase of new materials
by reusing them. Materials and methods: A bibliographic and
documentary narrative review was carried out using LILACS
and NCBI as database, with previously defined filters and
selection criteria. Resultados: Decontamination, disinfection,
conditioning, sterilization, and quality control tests are critical
stages and, therefore, require training. Each of these stages also
has characteristic risks, which must be minimized. In order to
ensure the quality of the catheter reuse process, after the cleaning
and sterilization process, techniques beyond microscopic
and visual evaluation of the device are required. A diversity
of techniques is addressed so that the quality of the process is
assured. Although legislation and supervision are divergent
around the world, many countries choose to adopt reprocessing
with economic justification in most cases. The reuse of
hospital devices involves several physico-chemical processes,
which must be performed with quality and safety. Conclusion:
The need for greater rigor in the norms and guidelines that
address this practice is clear and urgent, as well as the greater
intensity and rigidity of the responsible inspection agencies.
The use of luminol as an indicator of organic contaminants
may generate a false positive result. Therefore, 3M™ Clean-
Trace ™ is the best instrument found in the world market to
ensure that the material that has been reused is free of organic
waste, and thus fit for use in hospitals.

Referências

Bomfim FM, Lima SG, Guimarães V. Análise do reprocessamento

de cateteres de hemodinâmica em uma capital brasileira.

Rev Bras Cardiol. 2013;26(1):33-39.

Ministério da Saúde (Brazil). DATASUS. Informações de Saúde.

Sistema de Informações Hospitalares do SUS [accessed in 21

aug 2018]. Available at: www.datasus.gov.br

Crawford TC, Eagle KA. Reuse of catheters and devices

labelled for single use: evidence, recommendations and oversight.

Heart Asia. 2018;10(2).

Mansur AP. Favarato D. Mortalidade por doenças cardiovasculares

no Brasil e na região metropolitana de São Paulo. Arq.

Bras. Cardiol. 2012;99(2):755-761.

Costa EA. Gerenciando risco em reprocessamento de produtos

para Saúde: Uma metodologia para serviços hospitalares.

Revista SOBECC 2013;18(2):33-44.

Buckley BS, Fader M, Macauley MS. Giving intermittent catheter

users more choice. Br J Gen Pract. 2015;65(637):419

Kapoor A, Vora AM, Natarai G, et al. Guidance on reuse of

cardio-vascular catheters and devices in India: A consensus

document. Indian Heart J. 2017;69:357-63.

Agência Nacional de Vigilância Sanitária (Brasil). Portaria nº 3

de 7 de fevereiro de 1986.

Agência Nacional de Vigilância Sanitária (Brasil). Portaria nº 4

de 7 de fevereiro de 1986.

Agência Nacional de Vigilância Sanitária (Brasil). RE nº 2605

de 11 de agosto de 2006.

Agência Nacional de Vigilância Sanitária (Brasil). RE nº 2606

de 11 de agosto de 2006.

Agência Nacional de Vigilância Sanitária (Brasil). RDC nº 156

de 11 de agosto de 2006.

Agência Nacional de Vigilância Sanitária (Brasil). Portaria nº 8

de 8 de julho de 1988.

Agência Nacional de Vigilância Sanitária (Brasil). RDC nº 15 de

de março de 2012.

Baffi, SH. Reprocessamento e reutilização de cateteres em hemodinâmica:

a busca de qualidade nesta prática. [Dissertação

de doutorado em Enfermagen] – Universidade de São Paulo;

Meijs AP, Ferreira JA, DE Greeff SC, et al. Incidence of

surgical site infections cannot be derived reliably from point

prevalence survey data in Dutch hospitals. Epidemiol Infect.

;145(5):970-980.

Humphreys, H. Preventing surgical site infection. Where now? J

Hosp Infect. 2009;73:316-22.

Ribeiro SM. Reprocessamento de cateteres de angiografia

cardiovascular após uso clínico e contaminados artificialmente:

avaliação da eficácia da limpeza e da esterilização. [Tese de

doutorado em Enfermagem] – Universidade de São Paulo;

Smith JJ, Henderson JA, Baim DS. The Food and Drug Administration

and reprocessing of single-use medical devices:

a revised policy and new questions. J Vasc Interv Radiol

;13(12):1179-1182.

Costa EA, Costa EA, Graziano KU, et al. Reprocessamento de

produtos médicos: uma proposta de modelo regulatório para

hospitais brasileiros. Rev Esc Enferm USP. 2011:45(6):1459-

Duffy RE, Couto B, Pessoa JM, et al. Improving water quality

can reduce pyrogenic reactions associated with reuse of cardiac

catheters. Infect. Control Hosp. Epidemiol. 2013;24(12):955-

Kuniyoshi RR, Sternick EB, Nadalin E, et al. Reprocessing

of Medical Products in Electrophysiology. Arq Bras Cardiol.

;108(2):169-172.

Mender RR, Albuquerque GS, Silva MN, et al. Reutilização de

cateteres cardíacos de eletrofisiologia. RELAMPA, Rev. Lat.-

Am. Marcapasso Arritm. 2011;24(3):151-160.

3M. 3M Surface Test para Mercado Hospitalar [accessed

in 21 aug 2018]. Available at: https://www.3m.com.br/3M/

pt_BR/3m-do-brasil/todos-os-produtos-3m-do-brasil/~/Todos-

os-Produtos-3M/Limpeza-e-Monitoramento-da-Esteriliza%

C3%A7%C3%A3o/Sa%C3%BAde/Mercado-Hospitalar/

Surface-Test/?N=5002385+8707795+8707798+8711017+87110

+8717846+3294857441&rt=r3>.

Sato A, Nakamura I, Fujita H, et al. Peripheral venous catheter-

related bloodstream infection is associated with severe

complications and potential death: a retrospective observational

study. BMC Infect Dis. 2017;17(1):434.

Amaranta JM, Toscano CM, Pearson ML, et al. Reprocessing

and reuse of single-usemedical devices used during hemodynamic

procedures in Brazil: a widespread and largely overlooked

problem. Infect. Control Hosp. Epidemiol. 2008;29:854–

Silva MV, Martinez MB, Andreoli J. Microbiological evaluation of

reused catheter guides in a Brazilian hospital. PDA J. Pharm.

Sci. Technol. 2006;60:356–365.

Popp W, Rasslan O, Unahalekhaka A, et al. What is the use?

An international look at reuse of single-use medical devices. Int

J Hyg Environ Health. 2010;213:302–7.

Wang D, Wu J. Reprocessing and reuse of single-use medical

devices in China: a pilot survey. BMC Public Health.

;19(1):461.

Costa EA. Panorama internacional do reprocessamento de produtos

médicos de uso único. Revista SOBECC. 2016;21:203.

Ischinger TA, Neubauer G, Ujaky R, et al. Wiederverwendung

von medizinischen Einwegprodukten nach qualitätsgesicherter

Wiederaufbereitung: ein Modell zur Kostendämpfung? Z. Kardiol,

;91:889–898.

European Commision. European Commission: synthesis

document – Outcome of the first public consultation on the

reprocessing of medical devices. May 2008; EAMDR (European

Association for Medical Device Reprocessing; SUPROMED

7

European Comission. European Commission: synthesis document.

Outcome of the first public consultation on the reprocessing

of medical devices. Brussels, 2008b.

Tessarolo F. Reuse of single-use medical devices for interventional

cardiology. Appl Surf Sci. 2004;238:341- 46.

Quirck M. Most US hospitals avoid reuse of single-use devices.

Lancet Infect. Dis. 2002;2:714.

United States Government Accontability Office (United States

of America) 2008. Report to the Committee on Oversight and

Government Reform, House of Representatives. Reprocessed

single-use medical devices. FDA Oversight Has Increased, and

Available Information Does Not Indicate That Use Presents an

Elevated Health Risk. GAO-08-147.

Alfa MJ, Castillo J. Impact of FDA policy change on the reuse of

single-use medical devices in Michigan hospitals. Am. J. Infect.

Control. 2014;32:337–341.

The Association of Perioperative registered nurses. AORN

guidance statement: reuse of single-use devices. AORN J.

;84:876–884.

Jacobs PD, Polisena J, Hailey D, et al. Economic analysis of

reprocessing single-use medical devices: A systematic literature

review. Infect. Control Hosp. Epidemiol. 2008;29(4):297-301.

Koh AL, Kawahara K. Current practices and problems in

the reuse of single-use devices in Japan. J. Med. Dent. Sci.

;52:81–89.

World Health Organization. The Joint Commission, Joint Commission

International: Single use of Injection Devices. WHO:

Geneva; 2007.

Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare

settings worldwide, 2000: literature review and regional

estimates. BMJ. 2003;327:1075–1078.

Collignon PJ, Dreimanis DE. Beckinha WD. Reuse of single-use

medical devices in sterile sites: how often does this still occur in

Australia? MJA. 2003;179:115–116

Hailey D, Jacobs PD, Ries NM, et al. Reuse of single use medical

devices in Canada: clinical and economic outcomes, legal

and ethical issues, and current hospital practice. Int. J. Technol.

Assess. Health Care. 2008;24:430–436.

Department of Health (Australia). Infection control guidelines

for the prevention of transmission of infectious diseases in the

health care setting. [accessed in 21 aug 2018]. Available at:

http://www.health.gov.au/internet/main/publishing.nsf/Content/

DEF2A0D0C4D47A69CA257BF0001B0827/$File/icg-rescinded.

pdf

Therapeutic Goods Administration (Australia). Australian regulatory

guidelines for medical devices. Version 1.1, May 2011.

[accessed in 21 aug 2018]. Available at: https://www.tga.gov.au/

sites/default/files/devices-argmd-01.pdf

Schmid GP, Buvé A, Mugyenyi P, et al Transmission of HIV-1 infection

in sub-Saharan Africa and effect of elimination of unsafe

injections. Lancet. 2004;363:482–488.

Jama ZV, Chin A, Badri M, et al. Performance of re-used pacemakers

and implantable cardioverter defibrillators compared

with new devices at Groote Schuur Hospital in Cape Town,

South Africa. Cardiovasc J Afr. 2015;26(4):181-7.

World Health Organization. Regional. Infection prevention and

control in health care: time for collaborative action. WHO: Committee

for the Eastern Mediterranean; 2010.

Raposo M. CME - O coração do hospital: Uma investigação ergonômica

em centrais de materiais esterelizados em unidades

públicas de saúde. [Dissertação de mestrado em Design] -

PUC-Rio de Janeiro: 2007.

Kapoor A, Vora A, Nataraj G, et al. Guidance on reuse of

cardio-vascular catheters and devices in India: A consensus

document. Indian Heart J. 2017; 69:357-63.

Oliveira AC, Gama CS. Avaliação da adesão às medidas para a

prevenção de infecções do sítio cirúrgico pela equipe cirúrgica.

Belo Horizonte: Rev Esc Enferm USP. 2015;49(5):767-74.

Veras BM, Senna KM, Correia MG, et al. Análise de custo-

efetividade do reuso de cateteres de cinecoronariografia

sob a perspectiva de uma instituição pública no Município do

Rio de Janeiro, Brasil. Cad. Saúde Pública, Rio de Janeiro.

;29:S110-S120.

Leite FB. Central de material esterilizado: projeto de reestruturação

e ampliação do hospital regional de Francisco Sá.

Brasília (DF): Ministério da Saúde; 2008.

Lucas CT, Barbosa MP, Oliveira AC. Validação do reprocessa-

Paula Z. P. F. Pinto, Nelson Massini • Legal and biological safety of legal reprocessing of medical-hospital materials

mento de cateteres cardíacos angiográficos: uma avaliação da

funcionalidade e da integridade. Rev Esc Enferm USP. 2010;

(4):947-955.

Patel G, Hopwood AJ. An evaluation of luminol formulations and

their effect on DNA profiling. J. Legal Med. 2013;127(4):723-

Mathews KC, Holde KE. Bioquímica. 2 ed. Madrid: McGraw-Hill/

Interamericana de España; 2000.

Ferreira AM, Andrade D, Rigotti MA, et al. Avaliação da desinfecção

de superfícies hospitalares por diferentes métodos de

monitoramento. Rev. Latino-Am. Enfermagem. 2015;23(3):466-

Agência Nacional de Vigilância Sanitária (Brazil). Resolução –

ANVISA/DC nº 48, de 2 de junho de 2000.

Bergervoet PW, Riessen NV, Zwet WC. Application of the

forensic Luminol for blood in infection control. J Hosp Infect.

;68(4):329-333.

Dilbeck, L. Use of Bluestar forensic in lieu of luminol at crime

scenes. Journal of Forensic Identification 2006;56(5):706.

Association for the Advancement of Medical Instrumentation

(United States of America). Comprehensive guide to steam

sterilization and sterility assurance in health care facilities 2017.

Associação Brasileira de Normas Técnicas (Brazil). Esterilização

de produtos para saúde - Indicadores biológicos - Parte

: Requisitos gerais. [accessed in 21 aug 2018]. Available at:

http://www.abnt.org.br/noticias>

Downloads

Publicado

2021-05-07

Como Citar

Pinto, P. Z. P. F., & Massini, N. (2021). Legal and biological safety of legal reprocessing of medicalhospital materials. Brazilian Journal of Health and Biomedical Sciences, 19(2), 130–141. https://doi.org/10.12957/bjhbs.2020.59717

Edição

Seção

Revisão de Literatura